Skip to content
PICO Portalanswers from OpenAlex

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study

PaperCitations, authors & open-access status

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prevalence, risk factors, and management of asthma in China: a national cross-sectional study have?

PICO Portalcitation count

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study has 773 citations in the OpenAlex counts PICO Portal stores.

When was Prevalence, risk factors, and management of asthma in China: a national cross-sectional study published?

PICO Portalyear

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study has 2019 year in the PICO Portal index.

What is the open-access status of Prevalence, risk factors, and management of asthma in China: a national cross-sectional study?

PICO Portaloa status

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study has green oa status in the PICO Portal index.

What is the DOI of Prevalence, risk factors, and management of asthma in China: a national cross-sectional study?

PICO Portaldoi

The DOI for Prevalence, risk factors, and management of asthma in China: a national cross-sectional study is on the source record.

What is the PMID of Prevalence, risk factors, and management of asthma in China: a national cross-sectional study?

PICO Portalpmid

The PMID for Prevalence, risk factors, and management of asthma in China: a national cross-sectional study is on the source record.

What is the OpenAlex record for Prevalence, risk factors, and management of asthma in China: a national cross-sectional study?

PICO Portalopenalex

The OpenAlex for Prevalence, risk factors, and management of asthma in China: a national cross-sectional study is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial